A novel protective role of prostaglandin D2 in antigen-induced bronchoconstriction Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020
Bronchoconstriction induced by prostaglandin D2 (PGD2 ) in guinea pig lung is enhanced by selective COX-2 inhibition Source: Eur Respir J 2006; 28: Suppl. 50, 759s Year: 2006
Prostaglandin D2 metabolite as a marker of asthma exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 424s Year: 2002
Fevipiprant inhibits eosinophil activation induced by multiple metabolites of prostaglandin D2 Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019
Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice Source: Eur Respir J 2009; 34: 200-208 Year: 2009
Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in the airway remodeling induced by chronic airway inflammation in guinea pigs Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008
Montelukast inhibits bronchoconstriction and gas exchange defects induced by leukotriene D4 challenge in asthma Source: Eur Respir J 2002; 20: Suppl. 38, 308s Year: 2002
Prostaglandin D2 (PGD2 ) and tryptase release into blood after adenosine and methacholine challenges in asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006
A fully dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a murine model of asthma Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010
Estrogen prevents airway hyperresponsiveness in a murine model of allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 433s Year: 2006
The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016
Budesonide-induced decrease of IL-5 production does not affect allergen-induced bronchoconstriction or AHR in a novel guinea pig asthma model Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019
Downregulation of prostaglandin E2 in bronchial fibroblasts of asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002
Resolvin E1 and E3 dampens asthmatic inflammation in a murine model Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020
Prostaglandin D2 a mediator of nasal obstruction Source: Eur Respir J 2001; 18: Suppl. 33, 427s Year: 2001
Involvement of eicosanoids and surfactant protein D in extrinsic allergic alveolitis Source: Eur Respir J 2005; 26: 1069-1073 Year: 2005
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007
Prostaglandin E2 prevents mast cell dependent bronchoconstrictrion via the EP2 receptor in human small airways Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma Year: 2015
Narirutin inhibits airway inflammation in an allergic mouse model Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 20s Year: 2004